| |
| |
|
| Insider
Information: |
Chang David D |
| Relationship: |
|
| City: |
Santa Monica |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
4,810,106 |
|
|
Indirect Shares
|
2,913,196 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
7,723,302 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Kite Pharma, Inc. |
KITE |
EVP, R&D, Chief Medica... |
2017-10-03 |
0 |
2014-06-25 |
0 |
Premium* |
|
|
Allogene Therapeutics, Inc. |
ALLO |
|
2024-05-16 |
4,810,106 |
2024-05-16 |
2,913,196 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
64 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
• – – |
2015-06-15 |
4 |
AS |
$55.93 |
$438,749 |
D/D |
(7,700) |
6,000 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
• – – |
2015-07-01 |
4 |
AS |
$61.15 |
$476,781 |
D/D |
(7,700) |
6,000 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
President and CEO |
• • – |
2021-05-24 |
4 |
OE |
$18.22 |
$499,410 |
D/D |
27,410 |
2,312,279 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
• – – |
2015-11-02 |
4 |
AS |
$68.27 |
$547,292 |
D/D |
(7,700) |
6,904 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
• – – |
2015-08-03 |
4 |
AS |
$71.15 |
$555,242 |
D/D |
(7,700) |
6,000 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
President and CEO |
• • – |
2018-10-15 |
4 |
B |
$18.00 |
$720,000 |
D/D |
40,000 |
1,995,625 |
2.81 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
President and CEO |
• • – |
2021-03-15 |
4 |
S |
$38.57 |
$791,271 |
D/D |
(20,513) |
2,204,417 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
President and CEO |
• • – |
2024-05-16 |
4 |
A |
$2.90 |
$1,000,001 |
D/D |
344,828 |
4,810,106 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
• – – |
2017-09-25 |
4 |
S |
$179.66 |
$1,424,196 |
D/D |
(7,927) |
57,423 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
• – – |
2017-04-03 |
4 |
AS |
$78.53 |
$1,630,866 |
D/D |
(20,000) |
50,165 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
• – – |
2017-05-01 |
4 |
AS |
$81.84 |
$1,641,744 |
D/D |
(20,000) |
50,165 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
• – – |
2015-11-10 |
4 |
AS |
$80.02 |
$2,464,616 |
D/D |
(30,800) |
6,904 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
• – – |
2017-10-03 |
4 |
D |
$180.00 |
$2,988,900 |
D/D |
(16,605) |
38,675 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
• – – |
2017-03-01 |
4 |
AS |
$79.11 |
$4,749,441 |
D/D |
(60,000) |
50,165 |
0 |
- |
|
64 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
